In a survey published in 2021, Brazil ranked third place in recent high-impact biomedical studies with psychedelics, mainly because of ayahuasca research initiated in the 1990s. However, clinical experimenters and humanities scholars still go their separate ways, without much cross-pollination between the two fields. They are in a unique position, though, to join forces and go beyond the narrow medicalization paradigm underpinning the psychedelic renaissance.